PAP
IRD

Persistent Asset Partners’s Opus Genetics IRD Stock Holding History

Persistent Asset Partners’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.5K Buy
+17,919
New +$62K 0.03% 249

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Persistent Asset Partners's IRD Position: Q1 2026 in Review

Persistent Asset Partners opened a new position in Opus Genetics (IRD) in Q1 2026: 17,919 shares worth $81.5K. The stake represents 0.03% of the portfolio and ranks #249 among its holdings.

79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Persistent Asset Partners held 17,919 shares of Opus Genetics worth $81.5K as of Q1 2026.
  • Opus Genetics was a new Persistent Asset Partners position in Q1 2026.
  • Opus Genetics made up 0.03% of Persistent Asset Partners's portfolio in Q1 2026, its #249 holding.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.